Special Issue "Antihypertensive Drugs"

Quicklinks

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (30 November 2009)

Special Issue Editors

Guest Editor
Prof. Dr. Giuseppe Mancia
Clinical Medicine Unit, University of Milano-Bicocca, San Gerardo Hospital, Via Pergolesi, 33, 20052 Monza (MI), Italy
E-Mail: giuseppe.mancia@unimib.it
Phone: +39 039 2333357
Fax: +39 039 322274
Interests: pathophysiology; clinical pharmacology and therapy of hypertension; congestive heart failure and other cardiovascular diseases

Guest Editor
Prof. Dr. Guido Grassi
Dipartimento di Medicina Clinica, Università Milano-Bicocca, Ospedale San Gerardo di Monza, Italy
E-Mail: guido.grassi@unimib.it

Special Issue Information

Dear Colleagues,

Hypertension has not always been recognized as a harbinger of cardiovascular complications and premature death. Only 70 years ago, hypertension was considered the body's adaptation to sclerotic blood vessel disease and essential to maintain organ perfusion; thus, treatment was regarded as undesirable. Epidemiologic studies have since established a strong linear relation between blood pressure and cardiovascular disease (CVD), and randomized trials have documented that blood pressure reductions by antihypertensive drugs confer cardiovascular protection, making the hypertension-related risk a reversible risk. There is now a consensus that blood pressure should be reduced to <140/90 mm Hg in all patients and that a more aggressive blood pressure target (<130/80 mm Hg) should be pursued in those in whom the cardiovascular risk is high. Despite this, blood pressure control remains elusive in most individuals in the hypertensive population, which makes improvement of blood pressure control in this population a priority goal. This goal may meet with new challenges, however. Optimal blood pressure control may have to include the measurement of blood pressure every day, given the fluctuations of blood pressure and their prognostic importance independent of and in addition to that of classically measured blood pressure values. This special issue of the journal will provide an up-to-date and comprehensive review of the drugs currently used in antihypertensive treatment.

Prof. Dr. Giuseppe Mancia
Prof. Dr. Guido Grassi
Guest Editors

Keywords

  • hypertension
  • antihypertensive treatment
  • ace-inhibitors
  • angiotensin II receptor blockers
  • diuretics
  • calcium antagonists
  • beta-blockers
  • blood pressure control
  • cardiovascular risk
  • clinical trials

Published Papers (17 papers)

Pharmaceuticals 2011, 4(1), 1-6; doi:10.3390/ph4010001
Received: 20 December 2010; Accepted: 22 December 2010 / Published: 23 December 2010
Show/Hide Abstract | Download PDF Full-text (36 KB) | View HTML Full-text | Download XML Full-text

Pharmaceuticals 2010, 3(4), 940-960; doi:10.3390/ph3040940
Received: 22 December 2009; in revised form: 25 February 2010 / Accepted: 8 March 2010 / Published: 29 March 2010
Show/Hide Abstract | Download PDF Full-text (98 KB) | Download XML Full-text
abstract graphic

Pharmaceuticals 2010, 3(4), 916-939; doi:10.3390/ph3040916
Received: 5 January 2010; in revised form: 4 March 2010 / Accepted: 18 March 2010 / Published: 26 March 2010
Show/Hide Abstract | Download PDF Full-text (206 KB) | Download XML Full-text

Pharmaceuticals 2010, 3(3), 441-447; doi:10.3390/ph3030441
Received: 18 December 2009; in revised form: 12 February 2010 / Accepted: 2 March 2010 / Published: 2 March 2010
Show/Hide Abstract | Download PDF Full-text (524 KB) | Download XML Full-text

Pharmaceuticals 2010, 3(2), 419-432; doi:10.3390/ph3020419
Received: 14 December 2009; in revised form: 29 January 2010 / Accepted: 2 February 2010 / Published: 4 February 2010
Show/Hide Abstract | Download PDF Full-text (148 KB)

Pharmaceuticals 2010, 3(1), 225-236; doi:10.3390/ph3010225
Received: 1 December 2009; in revised form: 28 December 2009 / Accepted: 5 January 2010 / Published: 19 January 2010
Show/Hide Abstract | Download PDF Full-text (222 KB) | Download XML Full-text

Pharmaceuticals 2010, 3(1), 237-250; doi:10.3390/ph3010237
Received: 8 December 2009; in revised form: 12 January 2010 / Accepted: 14 January 2010 / Published: 19 January 2010
Show/Hide Abstract | Download PDF Full-text (108 KB) | Download XML Full-text

Pharmaceuticals 2010, 3(1), 251-272; doi:10.3390/ph3010251
Received: 23 December 2009; in revised form: 14 January 2010 / Accepted: 18 January 2010 / Published: 19 January 2010
Show/Hide Abstract | Download PDF Full-text (211 KB) | Download XML Full-text

Pharmaceuticals 2010, 3(1), 59-109; doi:10.3390/ph3010059
Received: 24 October 2009; in revised form: 24 December 2009 / Accepted: 6 January 2010 / Published: 7 January 2010
Show/Hide Abstract | Download PDF Full-text (1857 KB) | Download XML Full-text

Pharmaceuticals 2010, 3(1), 1-9; doi:10.3390/ph3010001
Received: 2 December 2009; in revised form: 29 December 2009 / Accepted: 31 December 2009 / Published: 5 January 2010
Show/Hide Abstract | Download PDF Full-text (86 KB) | Download XML Full-text

Pharmaceuticals 2009, 2(3), 217-227; doi:10.3390/ph2030217
Received: 10 November 2009; in revised form: 12 December 2009 / Accepted: 16 December 2009 / Published: 18 December 2009
Show/Hide Abstract | Download PDF Full-text (901 KB) | Download XML Full-text

Pharmaceuticals 2009, 2(3), 168-183; doi:10.3390/ph203168
Received: 11 November 2009; in revised form: 1 December 2009 / Accepted: 2 December 2009 / Published: 9 December 2009
Show/Hide Abstract | Download PDF Full-text (612 KB) | Download XML Full-text

Pharmaceuticals 2009, 2(3), 125-133; doi:10.3390/ph2030125
Received: 26 November 2009; Accepted: 30 November 2009 / Published: 1 December 2009
Show/Hide Abstract | Download PDF Full-text (201 KB) | Download XML Full-text

Pharmaceuticals 2009, 2(3), 118-124; doi:10.3390/ph2030118
Received: 21 October 2009; in revised form: 14 November 2009 / Accepted: 17 November 2009 / Published: 27 November 2009
Show/Hide Abstract | Download PDF Full-text (41 KB) | Download XML Full-text |  Correction

Pharmaceuticals 2009, 2(3), 82-93; doi:10.3390/ph2030082
Received: 22 September 2009; in revised form: 9 November 2009 / Accepted: 13 November 2009 / Published: 16 November 2009
Show/Hide Abstract | Download PDF Full-text (169 KB) | Download XML Full-text

Pharmaceuticals 2009, 2(3), 66-76; doi:10.3390/ph2030066
Received: 10 August 2009; in revised form: 21 September 2009 / Accepted: 27 September 2009 / Published: 28 September 2009
Show/Hide Abstract | Download PDF Full-text (150 KB) | Download XML Full-text

Pharmaceuticals 2009, 2(2), 44-48; doi:10.3390/ph2020044
Received: 23 July 2009; in revised form: 4 September 2009 / Accepted: 11 September 2009 / Published: 11 September 2009
Show/Hide Abstract | Download PDF Full-text (30 KB) | Download XML Full-text

Last update: 4 March 2014

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert